Metcor Indications/Uses

Endocrine disorders : primary or secondary adrenocortical insufficiency.
As an adjunctive therapy for short term administration in rheumatoid arthritis, juvenile rheumatoid arthritis, ankylosing spondylitis, acute and subacute bursitis, synovitis of osteoarthritis, acute non-specific tenosynovitis, post-traumatic osteoarthritis, psoriatic arthritis, epicondylitis, acute gouty arthritis.
Collagen diseases : systemic lupus erythematosus, systemic dermatomyositis (polymyositis), acute rheumatic carditis.
Dermatologic diseases : bullous dermatitis herpetiformis, severe erythema multiforme (Stevens-Johnson Syndrome), severe seborrheic dermatitis, exfoliative dermatitis, mycosis fungoides, pemphigus, severe psoriasis.
Ophthalmic diseases : allergic corneal marginal ulcers, herpes zoster ophthalmicus, anterior segment inflammation, diffuse posterior uveitis and choroiditis, sympathetic ophthalmia, keratitis optic neuritis, allergic conjunctivitis, chorioretinitis, iritis, and iridocyclitis.
Respiratory diseases : symptomatic sarcoidosis, berylliosis, Loeffler's Syndrome, fulminating or disseminated pulmonary tuberculosis when used concurrently with appropriate antituberculous chemotherapy, aspiration pneumonitis.
Hematologic disorders : idiopathic thrombocytopenic purpura in adults, secondary thrombocytopenia in adults, autoimmune hemolytic anemia, erythroblastopenia (RBC anemia), congenital (erythroid) hypoplastic anemia.
For palliative management of leukemias and lymphomas in adults, acute leukemia of childhood.
Acute exacerbations of multiple sclerosis, allergic states, autoimmune diseases, and edematous states.